Prof. Andrzej Dziembowski, the leader of HERO/WIB project and the Head of RNA Biology Laboratory - ERA Chairs Group has recently given an interview for Biotechnologia.pl, in which he talks about the goals of the HERO/WIB project, the advantages of precision therapies in oncology, the challenges of personalized medicine and the most innovative directions for the biotechnology and pharmaceutical industry. We highly rocommend watching it! The interview is under the LINK